(Q42666223)

English

Pharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosing

scientific article published on 5 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pharmacokinetic and tolerability profile of pridopidine in healthy-volunteer poor and extensive CYP2D6 metabolizers, following single and multiple dosing (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

P Lindskov Krog

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

O Osterberg

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

P Gundorf Drewes

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Å Rembratt

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Schultz

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

W Timmer

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

5 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Drug Metabolism and Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

43-51

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

https://scigraph.springernature.com/pub.10.1007/s13318-012-0100-2

0 references

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

In vivo pharmacology of the dopaminergic stabilizer pridopidine

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Pharmacologic approaches to the treatment of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS13318-012-0100-2

21 January 2018

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/22948856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22948856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22948856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13318-012-0100-2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42666223&oldid=2143725552"